Dinakar Singh

Dinakar Singh, founder and CEO of Axon, shares a heartfelt journey marked by his child's battle with spinal muscular atrophy (SMA). He explores the emotional and financial motivations behind his commitment to developing life-saving drugs. Discussing the challenges of gene therapy and the pressing need for innovative treatments, he highlights grassroots efforts and collaboration in the biotech industry. Singh emphasizes the importance of community support and reforms to improve access to essential medications for families facing rare diseases.